What is the recommended dose of chlorpheniramine (antihistamine) maleate in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Chlorpheniramine Maleate in Children

The recommended oral dose of chlorpheniramine maleate for children is age-dependent: children 6-12 years should take 1/2 tablet (2 mg) every 4-6 hours, not exceeding 3 tablets in 24 hours, while children under 6 years should not use oral chlorpheniramine. 1

Oral Dosing Guidelines

  • For children 12 years and older: 1 tablet (4 mg) every 4-6 hours, not exceeding 6 tablets in 24 hours 1
  • For children 6 to under 12 years: 1/2 tablet (2 mg) every 4-6 hours, not exceeding 3 tablets in 24 hours 1
  • For children under 6 years: oral chlorpheniramine is not recommended 1

Parenteral Dosing for Special Situations (e.g., Anaphylaxis)

When parenteral administration is required in emergency situations such as anaphylaxis management:

  • Children over 12 years: 10 mg IM or IV slowly 2, 3
  • Children 6-12 years: 5 mg IM or IV slowly 2, 3
  • Children 6 months to 6 years: 2.5 mg IM or IV slowly 2, 3
  • Children under 6 months: 250 μg/kg IM or IV slowly 2, 3

Pharmacokinetic Considerations

  • Chlorpheniramine has a mean serum half-life of approximately 13.1 hours in children 6-16 years 4
  • The volume of distribution averages 7.0 L/kg, suggesting significant tissue binding 4
  • Therapeutic serum concentrations range from 2.3-12.1 ng/mL for symptom suppression 4
  • Pharmacokinetic studies indicate that age-/weight-based dosing achieves similar maximum concentration (Cmax) and area under the curve (AUC) across pediatric age groups 5

Important Clinical Considerations

  • Chlorpheniramine should be used as adjunctive therapy after epinephrine in anaphylaxis management, never as first-line treatment 3
  • Sedation is the most common adverse effect and appears to be more prevalent in children 2-5 years old 5
  • First-generation antihistamines like chlorpheniramine can cause reduced concentration and performance 3
  • Due to first-pass metabolism, only 25-45% of orally administered chlorpheniramine reaches systemic circulation 6

Precautions

  • Use with caution in children with asthma, as antihistamines can potentially thicken bronchial secretions 7
  • Monitor for excessive sedation, especially in younger children 5
  • Consider the sedating effects when administering during daytime, particularly for school-aged children 3
  • Avoid use in children with severe renal impairment 3

Alternative Routes of Administration

  • While oral administration is most common, intravenous and intramuscular routes are documented for specific clinical scenarios such as anaphylaxis 7, 2
  • Topical formulations may be beneficial for localized allergic reactions, though these are not commonly available in standard pediatric practice 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Chlorpheniramine Maleate Dosage and Usage Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pharmacokinetics and efficacy of chlorpheniramine in children.

The Journal of allergy and clinical immunology, 1982

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.